Development of Bispecific NT-PSMA Heterodimer for Prostate Cancer Imaging: A Potential Approach to Address Tumor Heterogeneity-Reference-Cited by-同舟云学术

Development of Bispecific NT-PSMA Heterodimer for Prostate Cancer Imaging: A Potential Approach to Address Tumor Heterogeneity

Published:2019-04-29 Issue:5 Volume:30 Page:1314-1322
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Ma Xiaofen¹²,Wang Mengzhe²,Wang Hui²,Zhang Tao²,Wu Zhanhong²,Sutton Mariia V.³,Popik Vladimir V.³^ORCID,Jiang Guihua¹,Li Zibo²^ORCID

Affiliation:

1. Department of Medical Imaging, Guangdong Second Provincial General Hospital, Guangzhou City, Guangdong Province 510317, P. R. China

2. Biomedical Research Imaging Center, Department of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

3. Department of Chemistry, University of Georgia, Athens, Georgia 30602, United States

Funder

Division of Chemistry

School of Medicine, University of North Carolina at Chapel Hill

National Institutes of Health

Science Foundation of Guangdong Second Provincial General hospital

Science and Technology Program of Guangzhou

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.9b00252

Reference40 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Cancer statistics, 2017

3. The complexity of prostate cancer: genomic alterations and heterogeneity

4. Phase 1 Radioimmunotherapy Study with Lutetium 177–labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma

5. Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R;Cancers;2023-04-18

2. Clinical advancement of precision theranostics in prostate cancer;Frontiers in Oncology;2023-02-02

3. Synthesis and Preclinical Evaluation of Three Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging;Molecules;2023-01-21

4. In vitro and in vivo comparative study of 68Ga-labeled DOTA-, NOTA-, and HBEDCC-chelated radiotracers targeting prostate-specific membrane antigen;Journal of Radioanalytical and Nuclear Chemistry;2023-01-19

5. PSMA-targeted low-molecular double conjugates for diagnostics and therapy;European Journal of Medicinal Chemistry;2021-12